Global Pharmacovigilance Software
Global Pharmacovigilance Software

Pharmacovigilance Software Comprehensive Study by End users (Pharma and Biotech Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other), Software (Oracle Argus Safety, ArisG, Oracle Adverse Event Reporting System, ClinTrace, PvNET, RepClinical, Others), Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software), Pharmacovigilance (Passive Surveillance, Active Surveillance, Cohort Event Monitoring, Targeted Clinical Investigations), Pharmacovigilance Component (Adverse Event Case Management, Aggregate Reporting, Signal Intelligence, Risk Management) Players and Region - Global Market Outlook to 2027

Pharmacovigilance Software Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Feb 2022 Edition 200 Pages 180 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Pharmacovigilance Software?
Pharmacovigilance software is a drug safety management software system for creating, classifying, reviewing, submitting, and maintaining pharmacovigilance data and adverse event reports. The goals of pharmacovigilance are to enhance patient care and safety in relation to the use of medicines and all medical and paramedical interventions; improve public health and safety in relation to the use of medicines; and detect and communicate concerns linked to the use of medicines.

The market study is broken down and major geographies with country level break-up.

The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Pharmacovigilance Software market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

ArisGlobal (United States), Ennov Solutions Inc. (United States), EXTEDO GmbH (United States), Online Business Applications, Inc. (United States), Oracle Corporation (United States), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (United States), United BioSource Corporation (United States), Ab Cube (France) and Max Application (Italy) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Veeva Systems (United States) and Phase Forward (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Pharmacovigilance Software market by Type, Application and Region.

On the basis of geography, the market of Pharmacovigilance Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End users, the sub-segment i.e. Pharma and Biotech Companies will boost the Pharmacovigilance Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Software, the sub-segment i.e. Oracle Argus Safety will boost the Pharmacovigilance Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Functionality , the sub-segment i.e. Adverse Event Reporting Software will boost the Pharmacovigilance Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Pharmacovigilance, the sub-segment i.e. Passive Surveillance will boost the Pharmacovigilance Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Pharmacovigilance Component , the sub-segment i.e. Adverse Event Case Management will boost the Pharmacovigilance Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In June 2019, Nordic Capital Fund IX announced an agreement to acquire US-headquartered ArisGlobal, a leading global provider of innovative SaaS software solutions, which are transforming the way the most successful life sciences companies handle drug safety, clinical development, regulatory compliance, and medical affairs.
In 2021, Certara, Inc., the global leader in biosimulation, announced the launch of its Secondary Intelligence™ software, the first and only software that quantitatively predicts the risk of adverse effects and safety issues derived from secondary pharmacology that may impede the clinical development of a drug.


Market Trend
  • Fully Integrated Software Expected to Grow
  • Growing Public and Private Investments in Pharmaceutical R&D in these Emerging Nations

Market Drivers
  • Rising Prevalence of Chronic Diseases
  • Increasing Incidence Rates of Adverse Drug Reactions

Opportunities
  • Growing Adoption of Pharmacovigilance Software by Organizations

Restraints
  • Lack of Skilled Pharmacovigilance Professionals
  • Adverse effects of Drugs

Challenges
  • Strict Government Regulations for Prior and Post Commercialization of Drugs


Key Target Audience
Pharma and Biotech Companies, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

1. What all players are profiled in the study?
The standard version of the report profiles players such as ArisGlobal (United States), Ennov Solutions Inc. (United States), EXTEDO GmbH (United States), Online Business Applications, Inc. (United States), Oracle Corporation (United States), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (United States), United BioSource Corporation (United States), Ab Cube (France) and Max Application (Italy) etc.

2. Can we have customized study for Pharmacovigilance Software Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. What would be the Market Size of Pharmacovigilance Software Market by 2027?
Analysts at AMA estimates Pharmacovigilance Software Market to reach USD Million by 2027.
Report Objectives / Segmentation Covered
By End users
  • Pharma and Biotech Companies
  • Contract Research Organizations
  • Business Process Outsourcing Firms
  • Other

By Software
  • Oracle Argus Safety
  • ArisG
  • Oracle Adverse Event Reporting System
  • ClinTrace
  • PvNET
  • RepClinical
  • Others

By Functionality
  • Adverse Event Reporting Software
  • Drug Safety Audits Software
  • Issue Tracking Software
  • Fully Integrated Software

By Pharmacovigilance
  • Passive Surveillance
  • Active Surveillance
  • Cohort Event Monitoring
  • Targeted Clinical Investigations

By Pharmacovigilance Component
  • Adverse Event Case Management
  • Aggregate Reporting
  • Signal Intelligence
  • Risk Management

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Diseases
      • 3.2.2. Increasing Incidence Rates of Adverse Drug Reactions
    • 3.3. Market Challenges
      • 3.3.1. Strict Government Regulations for Prior and Post Commercialization of Drugs
    • 3.4. Market Trends
      • 3.4.1. Fully Integrated Software Expected to Grow
      • 3.4.2. Growing Public and Private Investments in Pharmaceutical R&D in these Emerging Nations
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmacovigilance Software, by End users, Software, Functionality , Pharmacovigilance, Pharmacovigilance Component and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Pharmacovigilance Software (Value)
      • 5.2.1. Global Pharmacovigilance Software by: End users (Value)
        • 5.2.1.1. Pharma and Biotech Companies
        • 5.2.1.2. Contract Research Organizations
        • 5.2.1.3. Business Process Outsourcing Firms
        • 5.2.1.4. Other
      • 5.2.2. Global Pharmacovigilance Software by: Software (Value)
        • 5.2.2.1. Oracle Argus Safety
        • 5.2.2.2. ArisG
        • 5.2.2.3. Oracle Adverse Event Reporting System
        • 5.2.2.4. ClinTrace
        • 5.2.2.5. PvNET
        • 5.2.2.6. RepClinical
        • 5.2.2.7. Others
      • 5.2.3. Global Pharmacovigilance Software by: Pharmacovigilance (Value)
        • 5.2.3.1. Passive Surveillance
        • 5.2.3.2. Active Surveillance
        • 5.2.3.3. Cohort Event Monitoring
        • 5.2.3.4. Targeted Clinical Investigations
      • 5.2.4. Global Pharmacovigilance Software Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Pharmacovigilance Software: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. ArisGlobal (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ennov Solutions Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. EXTEDO GmbH (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Online Business Applications, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Oracle Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sarjen Systems Pvt. Ltd (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sparta Systems, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. United BioSource Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Ab Cube (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Max Application (Italy)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pharmacovigilance Software Sale, by End users, Software, Functionality , Pharmacovigilance, Pharmacovigilance Component and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Pharmacovigilance Software (Value)
      • 7.2.1. Global Pharmacovigilance Software by: End users (Value)
        • 7.2.1.1. Pharma and Biotech Companies
        • 7.2.1.2. Contract Research Organizations
        • 7.2.1.3. Business Process Outsourcing Firms
        • 7.2.1.4. Other
      • 7.2.2. Global Pharmacovigilance Software by: Software (Value)
        • 7.2.2.1. Oracle Argus Safety
        • 7.2.2.2. ArisG
        • 7.2.2.3. Oracle Adverse Event Reporting System
        • 7.2.2.4. ClinTrace
        • 7.2.2.5. PvNET
        • 7.2.2.6. RepClinical
        • 7.2.2.7. Others
      • 7.2.3. Global Pharmacovigilance Software by: Pharmacovigilance (Value)
        • 7.2.3.1. Passive Surveillance
        • 7.2.3.2. Active Surveillance
        • 7.2.3.3. Cohort Event Monitoring
        • 7.2.3.4. Targeted Clinical Investigations
      • 7.2.4. Global Pharmacovigilance Software Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmacovigilance Software: by End users(USD Million)
  • Table 2. Pharmacovigilance Software Pharma and Biotech Companies , by Region USD Million (2016-2021)
  • Table 3. Pharmacovigilance Software Contract Research Organizations , by Region USD Million (2016-2021)
  • Table 4. Pharmacovigilance Software Business Process Outsourcing Firms , by Region USD Million (2016-2021)
  • Table 5. Pharmacovigilance Software Other , by Region USD Million (2016-2021)
  • Table 6. Pharmacovigilance Software: by Software(USD Million)
  • Table 7. Pharmacovigilance Software Oracle Argus Safety , by Region USD Million (2016-2021)
  • Table 8. Pharmacovigilance Software ArisG , by Region USD Million (2016-2021)
  • Table 9. Pharmacovigilance Software Oracle Adverse Event Reporting System , by Region USD Million (2016-2021)
  • Table 10. Pharmacovigilance Software ClinTrace , by Region USD Million (2016-2021)
  • Table 11. Pharmacovigilance Software PvNET , by Region USD Million (2016-2021)
  • Table 12. Pharmacovigilance Software RepClinical , by Region USD Million (2016-2021)
  • Table 13. Pharmacovigilance Software Others , by Region USD Million (2016-2021)
  • Table 14. Pharmacovigilance Software: by Pharmacovigilance(USD Million)
  • Table 15. Pharmacovigilance Software Passive Surveillance , by Region USD Million (2016-2021)
  • Table 16. Pharmacovigilance Software Active Surveillance , by Region USD Million (2016-2021)
  • Table 17. Pharmacovigilance Software Cohort Event Monitoring , by Region USD Million (2016-2021)
  • Table 18. Pharmacovigilance Software Targeted Clinical Investigations , by Region USD Million (2016-2021)
  • Table 19. South America Pharmacovigilance Software, by Country USD Million (2016-2021)
  • Table 20. South America Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 21. South America Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 22. South America Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 23. South America Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 24. South America Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 25. Brazil Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 26. Brazil Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 27. Brazil Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 28. Brazil Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 29. Brazil Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 30. Argentina Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 31. Argentina Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 32. Argentina Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 33. Argentina Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 34. Argentina Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 35. Rest of South America Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 36. Rest of South America Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 37. Rest of South America Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 38. Rest of South America Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 39. Rest of South America Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 40. Asia Pacific Pharmacovigilance Software, by Country USD Million (2016-2021)
  • Table 41. Asia Pacific Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 42. Asia Pacific Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 43. Asia Pacific Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 44. Asia Pacific Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 45. Asia Pacific Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 46. China Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 47. China Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 48. China Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 49. China Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 50. China Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 51. Japan Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 52. Japan Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 53. Japan Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 54. Japan Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 55. Japan Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 56. India Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 57. India Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 58. India Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 59. India Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 60. India Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 61. South Korea Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 62. South Korea Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 63. South Korea Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 64. South Korea Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 65. South Korea Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 66. Taiwan Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 67. Taiwan Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 68. Taiwan Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 69. Taiwan Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 70. Taiwan Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 71. Australia Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 72. Australia Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 73. Australia Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 74. Australia Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 75. Australia Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 76. Rest of Asia-Pacific Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 77. Rest of Asia-Pacific Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 78. Rest of Asia-Pacific Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 79. Rest of Asia-Pacific Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 80. Rest of Asia-Pacific Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 81. Europe Pharmacovigilance Software, by Country USD Million (2016-2021)
  • Table 82. Europe Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 83. Europe Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 84. Europe Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 85. Europe Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 86. Europe Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 87. Germany Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 88. Germany Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 89. Germany Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 90. Germany Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 91. Germany Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 92. France Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 93. France Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 94. France Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 95. France Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 96. France Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 97. Italy Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 98. Italy Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 99. Italy Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 100. Italy Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 101. Italy Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 102. United Kingdom Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 103. United Kingdom Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 104. United Kingdom Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 105. United Kingdom Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 106. United Kingdom Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 107. Netherlands Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 108. Netherlands Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 109. Netherlands Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 110. Netherlands Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 111. Netherlands Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 112. Rest of Europe Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 113. Rest of Europe Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 114. Rest of Europe Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 115. Rest of Europe Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 116. Rest of Europe Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 117. MEA Pharmacovigilance Software, by Country USD Million (2016-2021)
  • Table 118. MEA Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 119. MEA Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 120. MEA Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 121. MEA Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 122. MEA Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 123. Middle East Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 124. Middle East Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 125. Middle East Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 126. Middle East Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 127. Middle East Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 128. Africa Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 129. Africa Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 130. Africa Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 131. Africa Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 132. Africa Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 133. North America Pharmacovigilance Software, by Country USD Million (2016-2021)
  • Table 134. North America Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 135. North America Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 136. North America Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 137. North America Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 138. North America Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 139. United States Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 140. United States Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 141. United States Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 142. United States Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 143. United States Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 144. Canada Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 145. Canada Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 146. Canada Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 147. Canada Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 148. Canada Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 149. Mexico Pharmacovigilance Software, by End users USD Million (2016-2021)
  • Table 150. Mexico Pharmacovigilance Software, by Software USD Million (2016-2021)
  • Table 151. Mexico Pharmacovigilance Software, by Functionality USD Million (2016-2021)
  • Table 152. Mexico Pharmacovigilance Software, by Pharmacovigilance USD Million (2016-2021)
  • Table 153. Mexico Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2016-2021)
  • Table 154. Company Basic Information, Sales Area and Its Competitors
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Pharmacovigilance Software: by End users(USD Million)
  • Table 165. Pharmacovigilance Software Pharma and Biotech Companies , by Region USD Million (2022-2027)
  • Table 166. Pharmacovigilance Software Contract Research Organizations , by Region USD Million (2022-2027)
  • Table 167. Pharmacovigilance Software Business Process Outsourcing Firms , by Region USD Million (2022-2027)
  • Table 168. Pharmacovigilance Software Other , by Region USD Million (2022-2027)
  • Table 169. Pharmacovigilance Software: by Software(USD Million)
  • Table 170. Pharmacovigilance Software Oracle Argus Safety , by Region USD Million (2022-2027)
  • Table 171. Pharmacovigilance Software ArisG , by Region USD Million (2022-2027)
  • Table 172. Pharmacovigilance Software Oracle Adverse Event Reporting System , by Region USD Million (2022-2027)
  • Table 173. Pharmacovigilance Software ClinTrace , by Region USD Million (2022-2027)
  • Table 174. Pharmacovigilance Software PvNET , by Region USD Million (2022-2027)
  • Table 175. Pharmacovigilance Software RepClinical , by Region USD Million (2022-2027)
  • Table 176. Pharmacovigilance Software Others , by Region USD Million (2022-2027)
  • Table 177. Pharmacovigilance Software: by Pharmacovigilance(USD Million)
  • Table 178. Pharmacovigilance Software Passive Surveillance , by Region USD Million (2022-2027)
  • Table 179. Pharmacovigilance Software Active Surveillance , by Region USD Million (2022-2027)
  • Table 180. Pharmacovigilance Software Cohort Event Monitoring , by Region USD Million (2022-2027)
  • Table 181. Pharmacovigilance Software Targeted Clinical Investigations , by Region USD Million (2022-2027)
  • Table 182. South America Pharmacovigilance Software, by Country USD Million (2022-2027)
  • Table 183. South America Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 184. South America Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 185. South America Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 186. South America Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 187. South America Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 188. Brazil Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 189. Brazil Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 190. Brazil Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 191. Brazil Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 192. Brazil Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 193. Argentina Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 194. Argentina Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 195. Argentina Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 196. Argentina Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 197. Argentina Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 198. Rest of South America Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 199. Rest of South America Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 200. Rest of South America Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 201. Rest of South America Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 202. Rest of South America Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 203. Asia Pacific Pharmacovigilance Software, by Country USD Million (2022-2027)
  • Table 204. Asia Pacific Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 205. Asia Pacific Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 206. Asia Pacific Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 207. Asia Pacific Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 208. Asia Pacific Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 209. China Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 210. China Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 211. China Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 212. China Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 213. China Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 214. Japan Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 215. Japan Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 216. Japan Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 217. Japan Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 218. Japan Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 219. India Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 220. India Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 221. India Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 222. India Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 223. India Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 224. South Korea Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 225. South Korea Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 226. South Korea Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 227. South Korea Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 228. South Korea Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 229. Taiwan Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 230. Taiwan Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 231. Taiwan Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 232. Taiwan Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 233. Taiwan Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 234. Australia Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 235. Australia Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 236. Australia Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 237. Australia Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 238. Australia Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 239. Rest of Asia-Pacific Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 240. Rest of Asia-Pacific Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 241. Rest of Asia-Pacific Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 242. Rest of Asia-Pacific Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 243. Rest of Asia-Pacific Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 244. Europe Pharmacovigilance Software, by Country USD Million (2022-2027)
  • Table 245. Europe Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 246. Europe Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 247. Europe Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 248. Europe Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 249. Europe Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 250. Germany Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 251. Germany Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 252. Germany Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 253. Germany Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 254. Germany Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 255. France Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 256. France Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 257. France Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 258. France Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 259. France Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 260. Italy Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 261. Italy Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 262. Italy Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 263. Italy Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 264. Italy Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 265. United Kingdom Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 266. United Kingdom Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 267. United Kingdom Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 268. United Kingdom Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 269. United Kingdom Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 270. Netherlands Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 271. Netherlands Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 272. Netherlands Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 273. Netherlands Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 274. Netherlands Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 275. Rest of Europe Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 276. Rest of Europe Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 277. Rest of Europe Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 278. Rest of Europe Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 279. Rest of Europe Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 280. MEA Pharmacovigilance Software, by Country USD Million (2022-2027)
  • Table 281. MEA Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 282. MEA Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 283. MEA Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 284. MEA Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 285. MEA Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 286. Middle East Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 287. Middle East Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 288. Middle East Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 289. Middle East Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 290. Middle East Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 291. Africa Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 292. Africa Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 293. Africa Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 294. Africa Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 295. Africa Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 296. North America Pharmacovigilance Software, by Country USD Million (2022-2027)
  • Table 297. North America Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 298. North America Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 299. North America Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 300. North America Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 301. North America Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 302. United States Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 303. United States Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 304. United States Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 305. United States Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 306. United States Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 307. Canada Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 308. Canada Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 309. Canada Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 310. Canada Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 311. Canada Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 312. Mexico Pharmacovigilance Software, by End users USD Million (2022-2027)
  • Table 313. Mexico Pharmacovigilance Software, by Software USD Million (2022-2027)
  • Table 314. Mexico Pharmacovigilance Software, by Functionality USD Million (2022-2027)
  • Table 315. Mexico Pharmacovigilance Software, by Pharmacovigilance USD Million (2022-2027)
  • Table 316. Mexico Pharmacovigilance Software, by Pharmacovigilance Component USD Million (2022-2027)
  • Table 317. Research Programs/Design for This Report
  • Table 318. Key Data Information from Secondary Sources
  • Table 319. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmacovigilance Software: by End users USD Million (2016-2021)
  • Figure 5. Global Pharmacovigilance Software: by Software USD Million (2016-2021)
  • Figure 6. Global Pharmacovigilance Software: by Pharmacovigilance USD Million (2016-2021)
  • Figure 7. South America Pharmacovigilance Software Share (%), by Country
  • Figure 8. Asia Pacific Pharmacovigilance Software Share (%), by Country
  • Figure 9. Europe Pharmacovigilance Software Share (%), by Country
  • Figure 10. MEA Pharmacovigilance Software Share (%), by Country
  • Figure 11. North America Pharmacovigilance Software Share (%), by Country
  • Figure 12. Global Pharmacovigilance Software share by Players 2021 (%)
  • Figure 13. Global Pharmacovigilance Software share by Players (Top 3) 2021(%)
  • Figure 14. Global Pharmacovigilance Software share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. ArisGlobal (United States) Revenue, Net Income and Gross profit
  • Figure 17. ArisGlobal (United States) Revenue: by Geography 2021
  • Figure 18. Ennov Solutions Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Ennov Solutions Inc. (United States) Revenue: by Geography 2021
  • Figure 20. EXTEDO GmbH (United States) Revenue, Net Income and Gross profit
  • Figure 21. EXTEDO GmbH (United States) Revenue: by Geography 2021
  • Figure 22. Online Business Applications, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Online Business Applications, Inc. (United States) Revenue: by Geography 2021
  • Figure 24. Oracle Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Oracle Corporation (United States) Revenue: by Geography 2021
  • Figure 26. Sarjen Systems Pvt. Ltd (India) Revenue, Net Income and Gross profit
  • Figure 27. Sarjen Systems Pvt. Ltd (India) Revenue: by Geography 2021
  • Figure 28. Sparta Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Sparta Systems, Inc. (United States) Revenue: by Geography 2021
  • Figure 30. United BioSource Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. United BioSource Corporation (United States) Revenue: by Geography 2021
  • Figure 32. Ab Cube (France) Revenue, Net Income and Gross profit
  • Figure 33. Ab Cube (France) Revenue: by Geography 2021
  • Figure 34. Max Application (Italy) Revenue, Net Income and Gross profit
  • Figure 35. Max Application (Italy) Revenue: by Geography 2021
  • Figure 36. Global Pharmacovigilance Software: by End users USD Million (2022-2027)
  • Figure 37. Global Pharmacovigilance Software: by Software USD Million (2022-2027)
  • Figure 38. Global Pharmacovigilance Software: by Pharmacovigilance USD Million (2022-2027)
  • Figure 39. South America Pharmacovigilance Software Share (%), by Country
  • Figure 40. Asia Pacific Pharmacovigilance Software Share (%), by Country
  • Figure 41. Europe Pharmacovigilance Software Share (%), by Country
  • Figure 42. MEA Pharmacovigilance Software Share (%), by Country
  • Figure 43. North America Pharmacovigilance Software Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • ArisGlobal (United States)
  • Ennov Solutions Inc. (United States)
  • EXTEDO GmbH (United States)
  • Online Business Applications, Inc. (United States)
  • Oracle Corporation (United States)
  • Sarjen Systems Pvt. Ltd (India)
  • Sparta Systems, Inc. (United States)
  • United BioSource Corporation (United States)
  • Ab Cube (France)
  • Max Application (Italy)
Additional players considered in the study are as follows:
Veeva Systems (United States) , Phase Forward (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation